455 related articles for article (PubMed ID: 31081997)
1. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
[TBL] [Abstract][Full Text] [Related]
2. Changing trends in aetiology-based hospitalizations with end-stage liver disease in the United States from 2016 to 2019.
Kim D; Perumpail BJ; Alshuwaykh O; Dennis BB; Cholankeril G; Ahmed A
Liver Int; 2022 Nov; 42(11):2390-2395. PubMed ID: 35906461
[TBL] [Abstract][Full Text] [Related]
3. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
[TBL] [Abstract][Full Text] [Related]
4. Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Ahmed A
Dig Dis Sci; 2021 Jan; 66(1):296-307. PubMed ID: 32124196
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
Hirode G; Saab S; Wong RJ
JAMA Netw Open; 2020 Apr; 3(4):e201997. PubMed ID: 32239220
[TBL] [Abstract][Full Text] [Related]
6. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
7. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
8. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
Kim D; Li AA; Perumpail BJ; Gadiparthi C; Kim W; Cholankeril G; Glenn JS; Harrison SA; Younossi ZM; Ahmed A
Hepatology; 2019 Mar; 69(3):1064-1074. PubMed ID: 30014489
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
[TBL] [Abstract][Full Text] [Related]
10. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study.
Gawrieh S; Dakhoul L; Miller E; Scanga A; deLemos A; Kettler C; Burney H; Liu H; Abu-Sbeih H; Chalasani N; Wattacheril J
Aliment Pharmacol Ther; 2019 Oct; 50(7):809-821. PubMed ID: 31475372
[TBL] [Abstract][Full Text] [Related]
11. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
Loomba R; Wong R; Fraysse J; Shreay S; Li S; Harrison S; Gordon SC
Aliment Pharmacol Ther; 2020 Jun; 51(11):1149-1159. PubMed ID: 32372515
[TBL] [Abstract][Full Text] [Related]
13. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
[TBL] [Abstract][Full Text] [Related]
14. Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States.
Konyn P; Perumpail BJ; Wijarnpreecha K; Cholankeril G; Ahmed A; Kim D
Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):113-119. PubMed ID: 38353612
[TBL] [Abstract][Full Text] [Related]
15. Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort study.
Simon TG; Roelstraete B; Hagström H; Loomba R; Ludvigsson JF
J Hepatol; 2023 Dec; 79(6):1366-1373. PubMed ID: 37604268
[TBL] [Abstract][Full Text] [Related]
16. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in South Auckland, New Zealand.
Hsiang JC; Bai WW; Raos Z; Stableforth W; Upton A; Selvaratnam S; Gane EJ; Gerred SJ
Intern Med J; 2015 Feb; 45(2):160-9. PubMed ID: 25371019
[TBL] [Abstract][Full Text] [Related]
18. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.
Pais R; Fartoux L; Goumard C; Scatton O; Wendum D; Rosmorduc O; Ratziu V
Aliment Pharmacol Ther; 2017 Nov; 46(9):856-863. PubMed ID: 28857208
[TBL] [Abstract][Full Text] [Related]
19. Data linkage to monitor hepatitis C-associated end-stage liver disease and hepatocellular carcinoma inpatient stays in England.
Ireland G; Simmons R; Hickman M; Harris R; Ramsay M; Sabin C; Mandal S
J Viral Hepat; 2020 Jan; 27(1):20-27. PubMed ID: 31505083
[TBL] [Abstract][Full Text] [Related]
20. Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.
Bruden DJT; McMahon BJ; Townshend-Bulson L; Gounder P; Gove J; Plotnik J; Homan C; Hewitt A; Barbour Y; Spradling PR; Simons BC; McArdle S; Bruce M
Hepatology; 2017 Jul; 66(1):37-45. PubMed ID: 28195349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
